Newborn neurobehavioral patterns are differentially related to prenatal maternal major depressive disorder and serotonin reuptake inhibitor treatment

Depression and Anxiety

Volumn 28, Issue 11, 2011, Pages 1008-1019

  Salisbury, Amy L ^a,b   Wisner, Katherine L ^c   Pearlstein, Teri ^b   Battle, Cynthia L ^b,d,e   Stroud, Laura ^b,f   Lester, Barry M ^a,b  

^a BROWN UNIVERSITY   (United States)

^b BROWN UNIVERSITY   (United States)

^c UNIVERSITY OF PITTSBURGH   (United States)

^d WOMEN AND INFANTS HOSPITAL   (United States)

^e BUTLER HOSPITAL   (United States)

^f MIRIAM HOSPITAL   (United States)

Author keywords

central nervous system; depression; infant; motor quality; pregnancy; treatment

Indexed keywords

ESCITALOPRAM; FLUOXETINE; PAROXETINE; SERTRALINE; VENLAFAXINE;

ADULT; ARTICLE; ATTENTION; BODY MOVEMENT; CHILD BEHAVIOR; COGNITION; CONTROLLED STUDY; DRUG EXPOSURE; FEMALE; GESTATIONAL AGE; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MATERNAL DISEASE; MOTOR PERFORMANCE; NEWBORN; NEWBORN ASSESSMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; STRESS;

ADULT; DEPRESSIVE DISORDER, MAJOR; FEMALE; GESTATIONAL AGE; HUMANS; INFANT BEHAVIOR; INFANT, NEWBORN; INFANT, NEWBORN, DISEASES; NEUROPSYCHOLOGICAL TESTS; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; PROSPECTIVE STUDIES; SEROTONIN UPTAKE INHIBITORS; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

EID: 81255166777     PISSN: 10914269     EISSN: 15206394     Source Type: Journal    
DOI: 10.1002/da.20883     Document Type: Article

References (82)

1. Bennett HA, Einarson A, Taddio A, Koren G, Einarson TR,. Prevalence of depression during pregnancy: systematic review. Obstet Gynecol 2004; 103: 698-709. (Pubitemid 40459031)
2. Gavin NI, Gaynes BN, Lohr KN, Meltzer-Brody S, Gartlehner G, Swinson T,. Perinatal depression: a systematic review of prevalence and incidence. Obstet Gynecol 2005; 106: 1071-1083. (Pubitemid 41532916)
3. Kalia M,. Neurobiological basis of depression: an update. Metabolism 2005; 54: 24-27. (Pubitemid 40546019)
4. Shaffery J, Hoffmann R, Armitage R,. The neurobiology of depression: perspectives from animal and human sleep studies. Neuroscientist 2003; 9: 82-98. (Pubitemid 36139582)
5. Ressler KJ, Nemeroff CB,. Role of serotonergic and noradrenergic systems in the pathophysiology of depression and anxiety disorders. Depress Anxiety 2000; 12: 2-19.
6. Field T, Diego M, Hernandez-Reif M, et al. Prenatal maternal biochemistry predicts neonatal biochemistry. Int J Neurosci 2004; 114: 933-945. (Pubitemid 38923889)
7. Field T, Diego M, Hernandez-Reif M, et al. Prenatal dopamine and neonatal behavior and biochemistry. Infant Behav Dev 2008; 31: 590-593.
8. Ponder KL, Salisbury A, McGonnigal B, Laliberte A, Lester B, Padbury JF,. Maternal depression and anxiety are associated with altered gene expression in the human placenta without modification by antidepressant use: Implications for fetal programming. Dev Psychobiol In Press. DOI: 10.1002/dev.20549.
9. Sandman CA, Wadhwa PD, Dunkel-Schetter C, et al. Psychobiological influences of stress and HPA regulation on the human fetus and infant birth outcomes. Ann N Y Acad Sci 1994; 739: 198-210.
10. Wadhwa PD,. Psychoneuroendocrine processes in human pregnancy influence fetal development and health. Psychoneuroendocrinology 2005; 30: 724-743. (Pubitemid 40775740)
11. Gitau R, Fisk NM, Teixeira JM, Cameron A, Glover V,. Fetal hypothalamic-pituitary-adrenal stress responses to invasive procedures are independent of maternal responses. J Clin Endocrinol Metab 2001; 86: 104-109. (Pubitemid 32109782)
12. Teixeira JM, Fisk NM, Glover V,. Association between maternal anxiety in pregnancy and increased uterine artery resistance index: cohort based study. Br Med J 1999; 318: 153-157. (Pubitemid 29192603)
13. Suri R, Altshuler L, Hellemann G, Burt VK, Aquino A, Mintz J,. Effects of antenatal depression and antidepressant treatment on gestational age at birth and risk of preterm birth. Am J Psychiatry 2007; 164: 1206-1213. (Pubitemid 47292409)
14. Van Dijk AE, Van Eijsden M, Stronks K, Gemke RJ, Vrijkotte TG,. Maternal depressive symptoms, serum folate status, and pregnancy outcome: results of the Amsterdam born children and their development study. Am J Obstet Gynecol 2010; 203: 563 e1-e7.
15. Wisner KL, Sit DK, Hanusa BH, et al. Major depression and antidepressant treatment: impact on pregnancy and neonatal outcomes. Am J Psychiatry 2009; 166: 557-566.
16. Butterfield LH, Disis ML, Fox BA, et al. A systematic approach to biomarker discovery; preamble to "the iSBTc-FDA taskforce on immunotherapy biomarkers." J Transl Med 2008; 6: 81.
17. Grote NK, Bridge JA, Gavin AR, Melville JL, Iyengar S, Katon WJ,. A meta-analysis of depression during pregnancy and the risk of preterm birth, low birth weight, and intrauterine growth restriction. Arch Gen Psychiatry 2010; 67: 1012-1024.
18. Alder J, Fink N, Bitzer J, Hosli I, Holzgreve W,. Depression and anxiety during pregnancy: a risk factor for obstetric, fetal and neonatal outcome? A critical review of the literature. J Matern Fetal Neonatal Med 2007; 20: 189-209. (Pubitemid 47221611)
19. Salisbury AL, Lester BM, Seifer R, et al. Prenatal cocaine use and maternal depression: effects on infant neurobehavior. Neurotoxicol Teratol 2007; 29: 331-340. (Pubitemid 46766692)
20. Zuckerman B, Bauchner H, Parker S, Cabral H,. Maternal depressive symptoms during pregnancy, and newborn irritability. J Dev Behav Pediatr 1990; 11: 190-194. (Pubitemid 20305889)
21. Jones NA, Field T, Fox N, Davalos M, Lundy B, GHart S,. Newborns of mothers with depressive symptoms are physiologically less developed. Infant Behav Dev 1998; 21: 537-541. (Pubitemid 128679799)
22. Armstrong KL, O'Donnell H, McCallum R, Dadds M,. Childhood sleep problems: association with prenatal factors and maternal distress/depression. J Paediatr Child Health 1998; 34: 263-266. (Pubitemid 28269751)
23. Singer LT, Garber R, Kliegman R,. Neurobehavioral sequelae of fetal cocaine exposure. J Pediatr 1991; 119: 667-672.
24. Albuquerque CA, Smith KR, Johnson C, Chao R, Harding R,. Influence of maternal tobacco smoking during pregnancy on uterine, umbilical and fetal cerebral artery blood flows. Early Hum Dev 2004; 80: 31-42. (Pubitemid 39201109)
25. Grassi-Zucconi G,. Effect of paradoxical sleep deprivation on DNA synthesis in fetal rat brain. Int J Dev Neurosci 1984; 2: 585-590. (Pubitemid 15185705)
26. Altman J, Das GD, Sudarshan K,. The influence of nutrition on neural and behavioral development. I. Critical review of some data on the growth of the body and the brain following dietary deprivation during gestation and lactation. Dev Psychobiol 1970; 3: 281-301.
27. Welder AA, Grant R, Kutschke RL, Anthony M, Bradlaw J, Acosta D,. Effects of maternal calorie-restricted diet on development of the foetal heart, as evaluated in primary cultures of rat myocardial cells. Food Chem Toxicol 1991; 29: 445-452.
28. Steer RA, Scholl TO, Hediger ML, Fischer RL,. Self-reported depression and negative pregnancy outcomes. J Clin Epidemiol 1992; 45: 1093-1099.
29. Grella CE,. Services for perinatal women with substance abuse and mental health disorders: the unmet need. J Psychoactive Drugs 1997; 29: 67-78. (Pubitemid 27175589)
30. Zaid A, Fullerton JT, Moore T,. Factors affecting access to prenatal care for U.S./Mexico border-dwelling Hispanic women. J Nurse Midwifery 1996; 41: 277-284. (Pubitemid 126755899)
31. Andrade SE, Raebel MA, Brown J, et al. Use of antidepressant medications during pregnancy: a multisite study. Am J Obstet Gynecol 2008; 198: 194.
32. Battle CL, Zlotnick C, Miller IW, Pearlstein T, Howard M,. Clinical characteristics of perinatal psychiatric patients: a chart review study. J Nerv Ment Dis 2006; 194: 369-377. (Pubitemid 43841203)
33. Yonkers KA, Wisner KL, Stewart DE, et al. The management of depression during pregnancy: a report from the American Psychiatric Association and the American College of Obstetricians and Gynecologists. Gen Hosp Psychiatry 2009; 31: 403-413.
34. Laine K, Heikkinen T, Ekblad U, Kero P,. Effects of exposure to selective serotonin reuptake inhibitors during pregnancy on serotonergic symptoms in newborns and cord blood monoamine and prolactin concentrations. Arch Gen Psychiatry 2003; 60: 720-726. (Pubitemid 36818634)
35. Anderson GM,. Peripheral and central neurochemical effects of the selective serotonin reuptake inhibitors (SSRIs) in humans and nonhuman primates: assessing bioeffect and mechanisms of action. Int J Dev Neurosci 2004; 22: 397-404. (Pubitemid 39233546)
36. Chambers CD, Johnson KA, Dick LM, Felix RJ, Jones KL,. Birth outcomes in pregnant women taking fluoxetine. N Engl J Med 1996; 335: 1010-1015. (Pubitemid 26338730)
37. Boucher N, Bairam A, Beaulac-Baillargeon L,. A new look at the neonate's clinical presentation after in utero exposure to antidepressants in late pregnancy. J Clin Psychopharmacol 2008; 28: 334-339.
38. Kallen B,. Neonate characteristics after maternal use of antidepressants in late pregnancy. Arch Pediatr Adolesc Med 2004; 158: 312-316. (Pubitemid 38451555)
39. Sanz EJ, De-las-Cuevas C, Kiuru A, Bate A, Edwards R,. Selective serotonin reuptake inhibitors in pregnant women and neonatal withdrawal syndrome: a database analysis. Lancet 2005; 365: 482-487. (Pubitemid 40215730)
40. Levinson-Castiel R, Merlob P, Linder N, Sirota L, Klinger G,. Neonatal abstinence syndrome after in utero exposure to selective serotonin reuptake inhibitors in term infants. Arch Pediatr Adolesc Med 2006; 160: 173-176. (Pubitemid 43213863)
41. Warburton W, Hertzman C, Oberlander TF,. A register study of the impact of stopping third trimester selective serotonin reuptake inhibitor exposure on neonatal health. Acta Psychiatr Scand 2010; 121: 471-479.
42. Oberlander TF, Eckstein Grunau R, Fitzgerald C, et al. Prolonged prenatal psychotropic medication exposure alters neonatal acute pain response. Pediatr Res 2002; 51: 443-453. (Pubitemid 34267314)
43. Oberlander TF, Grunau RE, Fitzgerald C, Papsdorf M, Rurak D, Riggs W,. Pain reactivity in 2-month-old infants after prenatal and postnatal serotonin reuptake inhibitor medication exposure. Pediatrics 2005; 115: 411-425. (Pubitemid 43193826)
44. Oberlander TF, Grunau R, Mayes L, et al. Hypothalamic-pituitary-adrenal (HPA) axis function in 3-month old infants with prenatal selective serotonin reuptake inhibitor (SSRI) antidepressant exposure. Early Hum Dev 2008; 84: 689-697.
45. Einarson A, Choi J, Einarson TR, Koren G,. Adverse effects of antidepressant use in pregnancy: an evaluation of fetal growth and preterm birth. Depress Anxiety 2010; 27: 35-38.
46. Oberlander TF, Warburton W, Misri S, Aghajanian J, Hertzman C,. Effects of timing and duration of gestational exposure to serotonin reuptake inhibitor antidepressants: population-based study. Br J Psychiatry 2008; 192: 338-343. (Pubitemid 351692377)
47. Simon GE, Cunningham ML, Davis RL,. Outcomes of prenatal antidepressant exposure. Am J Psychiatry 2002; 159: 2055-2061. (Pubitemid 35423865)
48. Kulin NA, Pastuszak A, Sage SR, et al. Pregnancy outcome following maternal use of the new selective serotonin reuptake inhibitors: a prospective controlled multicenter study. [see comment]. J Am Med Assoc 1998; 279: 609-610. (Pubitemid 28110208)
49. Suri R, Altshuler L, Hendrick V, Rasgon N, Lee E, Mintz J,. The impact of depression and fluoxetine treatment on obstetrical outcome. Arch Women Ment Health 2004; 7: 193-200. (Pubitemid 38981242)
50. Cohen LS, Heller VL, Bailey JW, Grush L, Ablon JS, Bouffard SM,. Birth outcomes following prenatal exposure to fluoxetine. Biol Psychiatry 2000; 48: 996-1000.
51. McElhatton PR,. The effects of benzodiazepine use during pregnancy and lactation. Reprod Toxicol 1994; 8: 461-475.
52. Spitzer RL, Williams JB, Gibbon M, First MB,. The structured clinical interview for DSM-III-R (SCID). I: History, rationale, and description. Arch Gen Psychiatry 1992; 49: 624-629.
53. Williams JB,. A structured interview guide for the Hamilton Depression Rating Scale. Arch Gen Psychiatry 1988; 45: 742-747.
54. Sobell LC, Brown J, Leo GI, Sobell MB,. The reliability of the alcohol timeline followback when administered by telephone and by computer. Drug Alcohol Depend 1996; 42: 49-54. (Pubitemid 26300639)
55. Sobell LC, Agrawal S, Annis H, et al. Cross-cultural evaluation of two drinking assessment instruments: alcohol timeline followback and inventory of drinking situations. Subst Use Misuse 2001; 36: 313-331. (Pubitemid 32294921)
56. Dum M, Sobell LC, Sobell MB, Heinecke N, Voluse A, Johnson K,. A quick drinking screen for identifying women at risk for an alcohol-exposed pregnancy. Addict Behav 2009; 34: 714-716.
57. Ingersoll K,. The impact of psychiatric symptoms, drug use, and medication regimen on non-adherence to HIV treatment. AIDS Care 2004; 16: 199-211. (Pubitemid 38183583)
58. Ingersoll KS, Farrell-Carnahan L, Cohen-Filipic J, et al. A pilot randomized clinical trial of two medication adherence and drug use interventions for HIV + crack cocaine users. Drug Alcohol Depend 2011; 116: 177-187.
59. Gottfried AW,. Measures of socioeconomic status in child development research: Data and recommendations. Merrill Palmer Quart 1985; 31: 85-92.
60. Lester BM, Tronick EZ,. History and description of the neonatal intensive care unit network neurobehavioral scale. Pediatrics 2004; 113: 634-640. (Pubitemid 38280775)
61. Maza PL, Wright LL, Bauer CR, et al. Maternal lifestyles study (MLS). Caretaking environment and stability of substance-exposed infants at one month corrected age. Ann N Y Acad Sci 1998; 846: 358-361.
62. Lester BM, Tronick EZ, LaGasse L, et al. Summary statistics of neonatal intensive care unit network neurobehavioral scale scores from the maternal lifestyle study: a quasinormative sample. Pediatrics 2004; 113: 668-675. (Pubitemid 38280777)
63. Lester BM, Tronick EZ, LaGasse L, et al. The maternal lifestyle study: effects of substance exposure during pregnancy on neurodevelopmental outcome in 1-month-old infants. Pediatrics 2002; 110: 1182-1192. (Pubitemid 35425195)
64. Stroud LR, Paster RL, Papandonatos GD, et al. Maternal smoking during pregnancy and newborn neurobehavior: effects at 10 to 27 days. J Pediatr 2009; 154: 10-16.
65. Liu J, Bann C, Lester B, et al. Neonatal neurobehavior predicts medical and behavioral outcome. Pediatrics 2010; 125: e90-e98.
66. Salisbury A, Lester B, Seifer R, et al. Prenatal cocaine use and maternal depression: effects on infant neurobehavior. Neurotoxicol Teratol 2007; 29: 331-340. (Pubitemid 46766692)
67. Field T,. Prenatal depression effects on the fetus and the newborn. Infant Behav Dev 2004; 27: 216-229.
68. Lundy B, Jones NA, Field T, et al. Prenatal depression effects on neonates. Infant Behav Dev 1999; 22: 119-129.
69. Tronick EZ, Olson K, Rosenberg R, Bohne L, Lu J, Lester BM,. Normative neurobehavioral performance of healthy infants on the neonatal intensive care unit network neurobehavioral scale. Pediatrics 2004; 113: 676-678. (Pubitemid 38280778)
70. Rampono J, Simmer K, Ilett KF, et al. Placental transfer of SSRI and SNRI antidepressants and effects on the neonate. Pharmacopsychiatry 2009; 42: 95-100.
71. Zeskind PS, Stephens LE,. Maternal selective serotonin reuptake inhibitor use during pregnancy and newborn neurobehavior. Obstet Gynecol Surv 2004; 59: 564-566.
72. Moses-Kolko EL, Bogen D, Perel J, et al. Neonatal signs after late in utero exposure to serotonin reuptake inhibitors: literature review and implications for clinical applications. JAMA 2005; 293: 2372-2383. (Pubitemid 40676760)
73. Oberlander TF, Misri S, Fitzgerald CE, Kostaras X, Rurak D, Riggs W,. Pharmacologic factors associated with transient neonatal symptoms following prenatal psychotropic medication exposure. J Clin Psychiatry 2004; 65: 230-237.
74. Casper RC, Fleisher BE, Lee-Ancajas JC, et al. Follow-up of children of depressed mothers exposed or not exposed to antidepressant drugs during pregnancy. J Pediatr 2003; 142: 402-408. (Pubitemid 36521227)
75. Pedersen LH, Henriksen TB, Olsen J,. Fetal exposure to antidepressants and normal milestone development at 6 and 19 months of age. Pediatrics 2010; 125: e600-e608.
76. Salisbury AL, Fallone MD, Lester B,. Neurobehavioral assessment from fetus to infant: the NICU network neurobehavioral scale and the fetal neurobehavior coding scale. Ment Retard Dev Disabil Res Rev 2005; 11: 14-20. (Pubitemid 40617417)
77. Gentile S,. Neurodevelopmental effects of prenatal exposure to psychotropic medications. Depress Anxiety 2010; 27: 675-686.
78. Deave T, Heron J, Evans J, Emond A,. The impact of maternal depression in pregnancy on early child development. BJOG 2008; 115: 1043-1051. (Pubitemid 351841766)
79. Pawlby S, Hay DF, Sharp D, Waters CS, O'Keane V,. Antenatal depression predicts depression in adolescent offspring: prospective longitudinal community-based study. J Affect Disord 2009; 113: 236-243.
80. Hay DF, Pawlby S, Waters CS, Sharp D,. Antepartum and postpartum exposure to maternal depression: different effects on different adolescent outcomes. J Child Psychol Psychiatry 2008; 49: 1079-1088.
81. Pilowsky DJ, Wickramaratne P, Talati A, et al. Children of depressed mothers 1 year after the initiation of maternal treatment: findings from the STAR*D-Child Study. Am J Psychiatry 2008; 165: 1136-1147.
82. Brennan PA, Pargas R, Walker EF, Green P, Newport DJ, Stowe Z,. Maternal depression and infant cortisol: influences of timing, comorbidity and treatment. J Child Psychol Psychiatry 2008; 49: 1099-1107.